Unapproved process parameter change during tech transfer – CAPA ineffectiveness identified


Published on 05/01/2026

Further reading: Manufacturing Deviation Case Studies

Analysis of Unapproved Process Parameter Changes During Tech Transfer

The pharmaceutical industry is governed by strict regulatory standards to ensure product safety and efficacy. However, deviations can occur, leading to non-compliance and potential harm to patient safety. In this case study, we will focus on a real-world example of an unapproved process parameter change during a tech transfer, the resultant investigations, corrective actions, and how organizations can learn from these incidents to improve their practices and maintain compliance.

To understand the bigger picture and long-term care, read this Manufacturing Deviation Case Studies.

By reading this article, you will learn how to effectively respond to similar deviations, including immediate containment actions, investigation workflows, and the development of a robust CAPA strategy. This approach can significantly enhance your inspection readiness for audits by regulatory bodies such as the FDA, EMA, and MHRA.

Symptoms/Signals on the Floor or in the Lab

During the tech transfer

of a solid oral dosage form, operators noticed deviations in product consistency and dissolution profile results, which raised immediate red flags. Quality Control (QC) analysts reported an increase in out-of-specification (OOS) results during routine testing. This prompted root cause analysis when a significant batch failed to meet product specifications post-approval.

Key symptoms observed included:

  • Inconsistent tablet weight variance exceeding 10% of the standard deviation.
  • Failure to meet dissolution criteria outlined in the dossier.
  • Increased complaints from stability testing indicating rapid degradation.

Documentation discrepancies were also identified, suggesting a potential unapproved alteration to the process parameters that occurred during tech transfer. These observations indicated that there were systemic issues affecting product quality and compliance.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the potential causes for deviations is critical for formulating an effective investigation strategy. Here is an analysis of the likely causes categorized into six key areas:

Category Likely Causes
Materials Use of raw materials with subpar quality, leading to inconsistent formulations.
Method Changes in mixing times not documented, leading to variations in homogeneity.
Machine Equipment malfunction or calibration issues affecting the manufacturing process.
Man Operator errors related to improper training or inadequate shift guidelines.
Measurement Inaccurate measurement techniques or systems not updated after process changes.
Environment Variation in environmental conditions during production affecting product stability.
Pharma Tip:  Batch executed with expired SOP during commercial campaign – root cause analysis failure explained

Investigation of these elements ensured a comprehensive assessment of potential errors contributing to the deviation.

Immediate Containment Actions (first 60 minutes)

In the first 60 minutes post-detection of the deviation, swift action is critical to limiting further product impact. Immediate containment actions included:

  • Quarantine of all affected batches produced post-tech transfer.
  • Immediate review of production logs and documentation to identify any undocumented parameter changes.
  • Notification of the Quality Assurance (QA) team and upper management as per the escalation procedure.
  • Initiation of a formal deviation report to document the observed anomalies and steps taken.
  • Temporary suspension of the production line while investigations commenced.

These actions aimed to prevent further distribution of non-compliant products and laid the groundwork for comprehensive investigations.

Investigation Workflow (data to collect + how to interpret)

A well-structured investigation workflow is essential to ascertain the root causes of the deviation. The following steps should be undertaken:

  1. Assemble Investigation Team: Form a cross-functional team comprising QA, QC, production, and technical representatives.
  2. Data Collection: Gather production logs, batch records, OOS reports, and any deviations. Pay attention to any adjustments made during tech transfer.
  3. Interviews: Conduct interviews with operators involved in the tech transfer to gather insights on any undocumented changes made.
  4. Trend Analysis: Review historical data for similar batches produced and analyze data integrity issues.
  5. Documentation Review: Evaluate validation protocols and training documents to identify gaps in compliance.

By methodically exploring these avenues, teams can uncover contributing factors to the deviation and refine their processes moving ahead.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Determining the true root cause of a deviation is crucial for effective CAPA implementation. Three effective tools that can be utilized are:

1. 5-Why Analysis

This technique involves asking “why” multiple times—typically five—to drill down to the fundamental issue. It is particularly useful when looking for the root causes of human error or procedural lapses.

2. Fishbone Diagram

This diagram helps in visualizing various categories of potential causes (Man, Machine, Method, Material, Measurement, Environment). It’s effective during brainstorming sessions with a cross-functional team to generate comprehensive insights.

3. Fault Tree Analysis

This deductive reasoning tool is useful when there are multiple pathways that could cause a single failure. It helps in laying out complex relationships between potential issues.

Pharma Tip:  Critical IPC skipped during routine manufacturing – root cause analysis failure explained

Choosing the appropriate tool depends on the complexity and nature of the identified symptoms. For instance, if human error is suspected, apply the 5-Why approach; for system or process failures, utilize Fishbone or Fault Tree Analysis.

CAPA Strategy (correction, corrective action, preventive action)

Upon identifying root causes, organizations must take a strategic approach to CAPA to address immediate issues and prevent future occurrences:

  • Correction: Re-test affected batches and assess their overall quality. Engage with suppliers regarding substandard materials if that is identified as a cause.
  • Corrective Action: Update the SOPs to include clearly defined process parameters and validations during tech transfer. Retrain all personnel involved to ensure understanding and compliance.
  • Preventive Action: Introduce periodic audits of tech transfer processes and implement stricter controls over parameter changes. Ensure any future changes undergo a formal review process.

Document all CAPA actions comprehensively to maintain compliance and provide a clear record for regulatory inspections.

Related Reads

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

A robust control strategy is necessary to monitor manufacturing processes effectively. Key elements for control strategies in this scenario include:

  • Statistical Process Control (SPC): Implementing SPC charts to monitor process deviations in real-time. This can prevent deviations before they escalate.
  • Regular Sampling: Establishing a comprehensive sampling plan to ensure product consistency and identify trends over time.
  • Alarms/Alerts: Setting up automated alerts for deviations from critical process parameters allows for immediate action.
  • Verification: Establish regular reviews of the monitoring systems, ensuring all equipment is calibrated and operating within specified limits.

By maintaining rigorous oversight through a control strategy, manufacturing operations can significantly mitigate risks associated with tech transfer deviations.

Validation / Re-qualification / Change Control Impact (when needed)

Any significant changes or deviations necessitate reassessment of validation protocols. In this instance:

  • Tech Transfer Validation: The process must be re-validated to ensure that all parameters remain within acceptable limits, particularly after CAPA implementation.
  • Change Control Documentation: All changes made as a result of the CAPA initiative must be documented through the change control process to support regulatory compliance.
  • Re-qualification: Consider re-qualifying equipment used during the transfer and ensuring that equipment adheres to original and revised specs.

Such steps ensure that any changes made do not adversely affect the quality of future batches and maintain compliance with regulatory expectations.

Inspection Readiness: What Evidence to Show (records, logs, batch docs, deviations)

Being prepared for inspections is critical, especially following a deviation. Inspectors expect to see clear evidence of compliance, and organizations should ensure that they have the following ready:

  • Detailed Deviation Reports documenting how the issue was identified, investigated, and resolved.
  • Complete batch records of affected products including logs of variations and corrective actions.
  • Quality Control test results showing historical data after implementing CAPA actions.
  • Training logs showing that personnel were updated on any changes in procedures.
  • Audit trails of changes made to the process during the tech transfer post-incident.
Pharma Tip:  Batch executed with expired SOP during commercial campaign – root cause analysis failure explained

By maintaining thorough documentation and evidence of responsiveness to the deviation, organizations will demonstrate their commitment to quality and compliance during inspections.

FAQs

What should I do if a deviation occurs during tech transfer?

Immediately initiate containment actions, document the deviation, and notify appropriate personnel to assess the situation.

How can I ensure compliance during tech transfers?

Establish clear standard operating procedures (SOPs) and controls, enforce rigorous training, and maintain documentation of all changes.

What tools can I use for root cause analysis?

Utilize tools like the 5-Why method, Fishbone diagram, or Fault Tree analysis to effectively identify the root cause of a deviation.

How should I structure a CAPA plan?

A CAPA plan should include corrective actions, further investigation into root causes, and preventive measures to avoid recurrence.

What documentation is necessary for inspection readiness?

Maintain complete deviation reports, batch records, training logs, and a history of quality control results.

What are common symptoms of process deviations?

Common symptoms include OOS results, product inconsistencies, and variations in expected performance metrics.

How often should I review processes for potential changes?

Regularly review processes, ideally after significant deviations or changes, and include periodic audits as part of a proactive compliance strategy.

Are unapproved changes legal in pharmaceutical manufacturing?

Unapproved changes can lead to regulatory non-compliance and are not permitted; all modifications must follow established change control procedures.

When should re-validation be considered?

Re-validation is necessary whenever process parameters are modified, new equipment is introduced, or following a significant deviation.

What are the effects of equipment malfunction on manufacturer compliance?

Equipment malfunction can result in deviations that impair product consistency, creating compliance risks and leading to potential recalls.

How does environmental control affect drug manufacturing quality?

Environmental factors can significantly influence product stability; maintaining strict environmental controls is essential to ensure quality standards.

What role does training play in preventing deviations?

Training is crucial in ensuring personnel understand processes thoroughly, helping to mitigate risks associated with human error during manufacturing.